|

Integrative Therapeutic Programme to Regulate Expressed Emotions Among Informal Caregivers of People With Dementia

RECRUITINGN/ASponsored by The University of Hong Kong
Actively Recruiting
PhaseN/A
SponsorThe University of Hong Kong
Started2025-12-20
Est. completion2026-09-30
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted

Summary

The dual-modal (face-to-face and online approaches), client-customized Caregivers Of dementia Processing Emotions (COPE) programme aims to 1. reduce caregivers' Expressed Emotion (EE), 2. reduce caregivers' depressive symptoms, 3. reduce the behaviourally interactive social dynamic of maladaptation (i.e., dysfunctional dyadic relationship and quality of care), and 4. improve caregivers' perceived stress from PwD's Behavioral and Psychological Symptoms of Dementia (BPSD). Researchers will compare COPE to a control group (standard therapy) to examine how effective the COPE programme is. Participants will take part in: Pretest prior to COPE implementation Post-test after COPE completion Follow up test in 3 months after COPE completion

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* (1) With a high level of EE as indicated by a cut-off score of 35 or above on the Family Attitude Scale (Chinese version; FAS-C)
* (2) Provides care at least 4 hours per day
* (3) Consent to participate
* (4) No acute psychiatric illness

Exclusion Criteria:

* (1) With a score below 35 on the Family Attitude Scale (Chinese version; FAS-C)
* (2) Provides care no more than 4 hours per day
* (3) Does not consent to participate
* (4) With acute psychiatric illness.

Conditions5

BPSD (Behavioral and Psycological Symptoms of Dementia)Caregiving StressDepressionDepressive SymptomExpressed Emotion

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.